|
July 10,
2002
THE
BREAST IMPLANT NIGHTMARE CONTINUES
A WEAK FDA
TAKES ANOTHER LOOK
By
Nicholas Regush
The big
news today was Hormone Replacement Therapy and why it may be more
harmful than beneficial. But another hugely important issue was being
given some scrutiny - again - by an FDA panel: breast implants.
When I
first began covering this issue extensively back in the 1980s, it was
very clear that there was no science to speak of - much like the lack
of science for hormone replacement. Women were essentially being
treated like guinea pigs. The culprits in the breast implant debacle
were plastic surgeons who didn’t have their heads screwed on
correctly. They thought anecdotes ("my patients are doing just fine")
were the equivalent to scientific research. Knowing the intellectual
profiles of some of these characters ( I had interviewed scores of
them), they still probably don’t get it. They think smiling
confidently through their pinched, sculpted, plastic faces somehow
absolves them of being known as stupid.
So,
after the FDA finally banned the science-free silicone implants for
widespread use, they are now still tackling the ones made with saline.
The agency actually approved the implants in May 2000 with the proviso
that a follow-up study be conducted. That might turn out to be a leap
that only brings further shame to plastic surgeons and their
manufacturer pals.
The
meeting held yesterday allowed two manufacturers of approved saline
inflatable breast implants to present their postmarket data to the FDA
panel. As far as I’m concerned, given what I know, they can blow it
out their ears. And if the FDA has any guts, it would yank the product
without further delay.
More
interesting and compelling is the prepared testimony of Kim Hoffman
(who has had three operations because of breast implants), who feels
strongly - and rightly so - that important information might have been
withheld from the FDA advisory panel back in May 2000.
Hoffman
is particularly perplexed that Mentor, one of the manufacturers given
approval for saline implants, was at the time under an open criminal
investigation for "allegations of serious irregularities in breast
implant studies" and other issues involving Mentor products.
The
Chairman of the House Commerce Committee was obviously wondering about
the same thing when he wrote to the FDA asking why the agency even
took the Mentor application to its advisory panel.
So,
asked Hoffman in her testimony yesterday, "Why should the FDA trust
the integrity of the [Mentor breast implant] data?"
So
then, come on FDA, answer Hoffman’s question. Meanwhile, what on earth
is Congress doing? Or is that an irrelevant question these days?
The
issue is science once again. Is it valid? Is Mentor Corporation going
by the book in manufacturing its products? Hoffman would like to know.
I would like to know. The American women thinking about having saline
breast implants SHOULD know. |